Vir Biotechnology
VIR
VIR
212 hedge funds and large institutions have $560M invested in Vir Biotechnology in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 83 increasing their positions, 61 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
212
Holders Change
-21
Holders Change %
-9.01%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
83
Reduced
61
Closed
40
Calls
$1.9M
Puts
$961K
Net Calls
+$936K
Net Calls Change
+$877K
Top Buyers
| 1 |
AVM
Arch Venture Management
Chicago,
Illinois
|
+$65.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$9.31M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.76M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.45M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$2.95M |
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.24M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$3.02M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.38M |
| 4 |
D.E. Shaw & Co
New York
|
-$2.37M |
| 5 |
BlackRock
New York
|
-$1.96M |
